NYSE ARCA | ETF
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.98% |
JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.15% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 3.11% |
ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.09% |
LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 2.99% |
VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.94% |
CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.92% |
CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 2.88% |
EWTX | Edgewise Therapeutics Inc | Healthcare | Biotechnology | 2.70% |
PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.63% |
AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.62% |
ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.52% |
TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 2.47% |
RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 2.47% |
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 2.38% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 2.36% |
PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.36% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.31% |
ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 2.30% |
PBH | Prestige Brand Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.96% |